|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 24.01 USD | -0.74% |
|
+1.72% | +27.26% |
| Dec. 03 | Pacira Biosciences reports inducement grants under Nasdaq Listing Rule | RE |
| Dec. 02 | Pacira Says Iovera Outperformed Radiofrequency Ablation in Chronic Low Back Pain | MT |
Main competitors
| Capi.($) | Investor | ESG MSCI | Fundamentals | Financial revisions | Global Valuation | Visibility | Consensus | ||
|---|---|---|---|---|---|---|---|---|---|
 | 1.04B | BB | |||||||
| 925B | A | |||||||
| 495B | BBB | |||||||
| 407B | AA | |||||||
| 335B | AA | |||||||
| 283B | A | |||||||
| 257B | AAA | |||||||
| 254B | A | |||||||
| 211B | A | |||||||
| 186B | A | |||||||
| 155B | AAA | |||||||
| 145B | BBB | |||||||
| 122B | A | |||||||
| 118B | AA | |||||||
| 104B | A | |||||||
| 98.15B | AA | |||||||
| 87.19B | AA | |||||||
| 63.66B | - | - | - | - | - | - | - | |
| 62.53B | AA | - | ||||||
| 57.33B | AA | |||||||
| Average | 218.35B | AA | |||||||
| Weighted average by Cap. | AA |
- Stock Market
- Equities
- PCRX Stock
- Sector Pacira BioSciences, Inc.
- Sector ratings
Select your edition
All financial news and data tailored to specific country editions
